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1. introduction 
Since the basic work of Stirpe and Fiume [l] on 
the action of cu-amanitin on RNA synthesis of mamma- 
lian cells, and after the demonstration that this toxic 
octapeptide product of Amanita phalloides acts on 
RNA polymerase of eukaryotes and not of bacteria 
[2] a great deal of work has been amassed concerning 
the mechanism of action of this substance (for a re- 
view see [3] ). A significant observation was that 
ol-amanitin preferentially inhibits RNA polymerase B 
[ 1, 51 the enzyme presumably responsible for the 
synthesis of DNA-like RNA, having no action on RNA 
polymerase A, the enzyme localized in the nucleolus 
[5], which synthesizes ribosomal RNA. This finding 
raised hopes that the long sought specific inhibitor of 
DNA-like RNA was found, which could be of great impor- 
tance for studies of control of RNA synthesis in higher 
organisms. However, in viva experiments demonstrated 
that a-amanitin impairs both DNA-like RNA as well 
as ribosomal RNA [6,7] showing less inhibitory ac- 
tion on low molecular RNA. The impairment of ribo- 
somal RNA synthesis after blocking of DNA-like RNA 
synthesis suggested [6,7] that the continuous synthe- 
sis of DNA-like RNA is necessary for the unimpaired 
functioning of the ribosomal RNA producing appara- 
tus. The experiments described below were designed 
to test this hypothesis. 
2. Materials and methods 
[3H]UTP (specific activity 1 Ci/mmole), [3H]orotic 
acid (specific activity 20-25 Ci/mmole) and [ 3 HIphen- 
ylalanine (specific activity 1 Ci/mmole) were obtained 
North-Holland Publishing Company - Amsterdam 
from the Radiochemical Centre, Amersham. The non- 
labelled nucleoside triphosphates were obtained from 
Boehringer, Mannheim. DE-32 cellulose (Whatman) 
was purchased from Hormuth and Vetter, Heidelberg. 
All other reagents were of analytical grade. Wistar BR 
II male rats weighing loo-120 g, kept under standard 
conditions, were used throughout. 
Rat liver nuclei were prepared according to 
Chauveau et al. as described in [8]. Nucleoli were pre- 
pared according to Bush [9]. 
Extraction of RNA polymerase from nuclei and 
chromatography on DEAE-cellulose was as described 
in [lo]. The in vitro RNA synthesizing system is des- 
cribed in [2]. The incorporation of [3H]phenylalanine 
in nucleolar proteins was determined according to [ 111. 
DNA was determined according to Burton [ 121. 
3. Results 
In a first series of experiments we examined the 
effects of administration of cY-amanitin on the in viuo 
labelling with RNA precursors of nuclear, nucleolar 
and extranucleolar RNA. As seen from fig. 1 there is 
within 15 min after the administration of ol-amanitin 
a significant decrease in the labelling of both extra- 
nucleolar and nucleolar RNA. The specific activity of 
the RNA of the nuclear fractions continues to decrease 
at 30 min and tends to level at 60 min. One possibility 
for the impairment of nucleolar RNA synthesis could 
be that cr-amanitin in viva is converted to a metabolite 
acting on RNA polymerase A. We therefore extracted 
and separated on DEAE-cellulose columns the RNA. 
polymerases from liver nuclei of control and a-amanitin 
treated rats and quantitated the activity of RNA poly- 
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Fig. 1. Effects of or-amanitin on the incorporation of [ 3H Jorotic 
acid into nuclear, nucleolar and extranucleolar RNA. cY-amanitin 
(lpg/g rat) was administered intraperitoneally, the animals kil- 
led at the time denoted in the ordinate of the figure after hav- 
ing received previously 15 min pulses of 25 nCi [ 3H Jorotic acid 
per rat. Nuclei, nucleolar and extranucleolar fractions were pre- 
pared and the incorporation of erotic acid into RNA measured. 
a) Nuclei; b) extranucleolar fraction; c) nucleoli. 
merase A and B recovered. Fig. 2 shows the results of 
such an experiment. It is evident that the amount of 
RNA polymerase assayed in nuclei of rats treated for 
1 hr with cu-amanitin is the same as that found in con- 
trol nuclei. Similar results have been obtained with 
nuclei from 2 hr treated animals. No RNA polymerase 
B activity can be detected in preparations from amani- 
tin treated rats. This could be due either to the failure 
to extract the enzyme from nuclei or to the extraction 
of the enzyme in an inactive form due to its binding 
with cr-amanitin. 
In order to differentiate between these possibilities 
we incubated minced liver with r4C-labelled-methyl 
cY-amanitin, then extracted and chromatographed 
nuclear RNA polymerases on DEAE-cellulose columns 
and further i) tested for RNA polymerase activity and 
ii) measured the “C-radioactivity in the different frac- 
tions. It can be seen (fig. 3) that radioactivity is found 
FRACTION NO 
Fig. 2. DEAE-cellulose chromatography of DNA-de+pendent 
RNA polymerase from liver nuclei of control and oi-amanitin 
treated rats. Amanitin was applied at a dose of 1 fig/g weight 
for 1 hr. Crude nuclei were prepared and the enzymes extracted 
and chromatographed as described by Seifart et al. [lo]. En- 
zyme assay was performed as described by Seifart and Sekeris 
[2]. Control (e-0-e); amanitin treated (X -X-X). 
in the fractions where enzyme B is normally isolated, 
which shows that the enzyme protein is present in the 
chromatograms but is inactive in the RNA synthesis 
assay for it is inhibited by bound cr-amanitin. 
We further tested the RNA synthetic capacity of 
isolated nuclei derived from control and cY-amanitin 
treated animals in the presence or absence of cY-amanitin 
and characterized RNA synthesis on the basis of its 
amanitin sensitivity. Fig. 4 shows that in contrast to 
in viva findings, nuclei from amanitin treated rats do 
not show decreased capacity to synthesize RNA in 
comparison to the controls. Not RNA synthesis in the 
nuclei from amanitin treated rats is nearly totally 
amanitin resistant. We then fractionated the nuclei 
into a nucleolar and an extranucleolar fraction and 
measured the RNA synthetic capacity of the two 
fractions in an in vitro system. Fig. 5 shows that nu- 
cleolar RNA synthesis is inhibited in the a-amanitin 
treated preparations similary to the in vivo experiments, 
whereas extranucleolar RNA synthesis is greatly enhan- 
ced. Both nucleolar and extranucleolar activities are 
amanitin resistant and stimulated preferentially by Mg”. 
These results taken together with the morphological 
findings of nucleolar segregation after amanitin action 
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Fig. 3. Binding of [ 14C]methyl-amanitin to rat liver nucleolar proteins. Rat liver was finely minced and incubated at with 1 fig/g 
tissue [14C]methyl-amanitin (specific activity 45.3 &i/mgj for 20 min at 22” in buffer. Crude nuclei were then prepared and RNA 
polymerase extracted and separated on DEAE-cellulose as described by Seifart et al. [lo]. L4C-radioactivity as well as the incorpo- 
ration of [ 3H]UTP in a standard RNA synthesizing mixture (Seifart and Sekeris, 1968) wasmeasured in aliquots of the fractions. 
[13, 141 suggested to us that polymerase A has leaked 
into the extranucleolar space. 
4. Discussion 
The impairment of ribosomal RNA synthesis could The experiments described above were performed 
be due to the lack of a special DNA-like RNA essential to explain some of the apparent inconsistencies be- 
for nucleolar structure and RNA synthesis or indirectly tween the in vivo and in vitro results obtained with 
to the lack of the translation product of the RNA. The a-amanitin. The main conclusions to be drawn is that 
first hypothesis is favoured by the very rapid and ex- RNA polymerase A is itself not impaired. However, 
tensive inhibition of nucleolar RNA synthesis which in vivo, the incorporation of labelled precursors into 
is seen 15 min after cu-amanitin application. The second both extranucleolar and nucleolar RNA is inhibited, 
hypothesis was suggested from data on the incorpora- whereas in vitro extranucleolar RNA synthesis is 
tion of labelled amino acids into nucleolar proteins. enhanced and gets qualities which are characteristic 
In table 1 the results of such an experiment is shown. for synthesis by RNA polymerase A. Nucleolar RNA 
[ 3 Hlphenylalanine was injected to control and c~aman- synthesis is inhibited as well as in vivo. It is conceivable 
itin treated rats and the specific activity of proteins, that in vivo under the action of amanitin RNA poly- 
of nuclei and nuclear fractions determined. Although merase leaks from the nucleoli into the extranucleolar 
general cytoplasmic and nuclear protein synthesis is space and that the polymerase in this case is either 
not influenced at all [ 1.51 incorporation of the amino not active in RNA synthesis or the RNA synthesized 
acid into nucleolar proteins is significantly inhibited. will be immediately digested by the nuclear nucleases. 
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Fig. 4. Effect of a-amanitin applied in vivo on RNA synthesis 
of isolated rat liver nuclei. Animals were treated with 1 pg/g 
cu-amanitin for different time periods. Rat liver nuclei were then 
prepared according to [8] and their RNA synthetic capacity 
measured asdescribed by Seifart and Sekeris [2] in the presence 
1.5 fig/ml and absence of or-amanitin. q : Amanitin sensitive 
cpm; 0: amanitin resistant cpm. 
Table 1 
Effect of cu-amanitin on the incorporation of [3H]phenylalanine 
into nuclear and cytoplasmic proteins. 
Incorporation 
Nuclei Control 
cr-Amanitin 
Nucleoli Control 
a-Amanitin 
Extranucleolar Control 
fraction a-Amanitin 
Post-mitochondrial Control 
fraction or-Amanitin 
(Cpm/mg (cpm/mg 
protein) DNA) 
3200 6240 
3580 5860 
1790 7 1400 
1200 32500 
4200 9150 
4770 9850 
11000 _ 
13000 _ 
Rats were injected 100 pCi/lOO g body weight [ 3H]phenyl- 
alanine 50 min before sacrifice follo$ed by either 1 pg/g body 
weight a-amanitin in saline or saline alone 30 min before 
sacrifice. Nuclei, nuclear fractions and post mitochondrial 
supernatant were prepared and the incorporation of [ 3H]phenyl- 
alanine in total proteins determined. 
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Fig. 5. Effect of a-amanitin applied in viva on RNA synthesis 
of isolated nuclei, extranucleolar fraction and nucleoli. Rats 
were treated with 1 Mg/g or-amanitin for different time periods. 
Rat liver nuclei, nucleoli and extranucleolar fraction were pre- 
pared and their RNA synthetic capacity determined in the 
presence of 5 pg/ml (o- -o- -0) and in the absence (e-o-o) 
of cu-amanitin. The incubation system was as described in [2] 
but instead of Mn, 19 mM MgCl2 was used. a) Nuclei; b) extra- 
nucleolar fraction and c) nucleoli. 
During the isolation of the nuclei this restriction of 
RNA synthesis could be lost so that in vitro RNA 
synthesis in the extranucleolar space by RNA poly- 
merase A can be detected. 
Our results do not prove whether the effect of 
a-amanitin on nucleolar RNA synthesis is exerted by 
the inhibition of the synthesis of a yet unknown DNA- 
like RNA which is an integral part of the nucleolus or 
whether amanitin acts by inhibiting transcription of 
the messenger RNA(s) of some essential nucleolar pro- 
tein(s) with a very short half life time. That protein 
synthesis is needed for the continuous synthesis of 
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ribosomal RNA has already been reported in experi- 
ments using cyclohexomide [ 16- 181 as inhibitor of 
protein synthesis. 
cu-Amanitin has been used lately as a specific inhibi- 
tor of DNA-like RNA synthesis in studies dealing with 
hormonal stimulation of RNA synthesis and on this 
basis [ 191 the hypothesis has been advanced that the 
stimulation of ribosomal RNA synthesis induced by 
hormones is a consequence of stimulation of synthesis 
of DNA-like RNA. This may well be so and is in fact 
favoured by our results showing a sequential stimula- 
tion by cortisol first of extranucleolar followed by 
nucleolar RN?A synthesis in rat liver [20, 211. However 
according to the data presented above caution should 
be applied in the interpretations of the results using 
a-amanitin, as its action is to block in uivo both DNA- 
like and ribosomal RNA which makes cu-amanitin, in 
end effect, a rather unspecific inhibitor of RNA syn- 
thesis. 
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